HyalDew MID with Lidocaine

Here is a 310-word description of HyalDew MID with Lidocaine:

HyalDew MID with Lidocaine: Balanced Premixed Monophasic HA Filler for Moderate Correction with Integrated Comfort

**HyalDew MID with Lidocaine**, manufactured by **A.M.I. (Advanced Medical Ingredients)**, is a **ready-to-use, monophasic, non-animal stabilized hyaluronic acid (NASHA) dermal filler** presented in a **1.0 ml prefilled syringe**. Positioned as the **mid-range** product in the HyalDew line, it features a **balanced viscosity** and **cohesive strength** ideal for correcting moderate wrinkles and restoring volume, **enhanced with integrated 0.3% lidocaine** for significantly improved patient comfort during injection. This premixed gel offers natural-looking lift and integration across key facial areas.https://skin-reboot.com/

**Core Technology & Properties:**
* **Premixed Monophasic NASHA Gel:** Contains **21 mg/ml** of highly purified, cross-linked hyaluronic acid. The monophasic structure ensures a homogeneous, smooth consistency for predictable tissue behavior.
* **Integrated 0.3% Lidocaine:** Provides effective local anesthesia during the procedure, crucial for patient tolerance in moderately sensitive areas.
* **Particle Size & Rheology:** Features a **medium particle size (approx. 500-800 µm)** and a **balanced, medium G-prime (elasticity)**. This delivers sufficient cohesive lift for moderate folds (like nasolabial folds) while ensuring good spreadability and a natural feel post-injection.
* **BDDE Cross-Linking:** Ensures biocompatibility and optimal longevity (typically 6-9 months) through controlled cross-linking density.
* **Versatile Viscosity:** Offers a practical balance between lifting power and ease of injection through needles or cannulas.

**Mechanism of Action:**
1. **Volumization & Lift:** The cohesive gel structure provides immediate volume restoration, lifting moderate wrinkles and folds upon precise placement.
2. **Hydration:** HA attracts and binds water molecules, enhancing skin hydration and contributing to a smoother, fuller appearance.
3. **Biostimulation:** Stimulates mild collagen and elastin production over time for sustained improvement.
4. **Anesthesia:** Lidocaine blocks sodium channels in local nerves, significantly reducing injection pain.

**Primary Indications:**
* **Moderate Nasolabial Folds:** Primary indication for lifting smile lines.
* **Moderate Marionette Lines:** Correcting downward-turning corners of the mouth.
* **Lip Augmentation:** Adding volume, structure, and definition to lips (body and border; lidocaine enhances comfort).
* **Perioral Rejuvenation:** Addressing moderate lines around the mouth.
* **Cheek Enhancement & Contouring:** Providing subtle lift and volume in the midface.
* **Chin Augmentation:** Enhancing chin projection and contour.
* **Temple Augmentation:** Restoring volume in the temporal region.

**Key Administration Considerations:**
* **Ready-to-Use:** No reconstitution needed. Prime syringe according to instructions.
* **Anesthesia:** Integrated lidocaine provides primary local anesthesia. Topical numbing cream is highly recommended adjunctively, especially for lips.
* **Technique:** Suitable for:
* **Linear Threading:** Primary technique for folds and lips (27-30G needles).
* **Fanning/Cross-Hatching:** For broader areas like cheeks/chins/temples.
* **Serial Puncture:** For precise placement in lips/perioral area.
* **Cannulas:** Compatible with 25-27G cannulas for deeper placement with potentially reduced bruising.
* **Depth:** Varies by area:
* **Nasolabial/Marionettes/Lips:** Mid-to-deep dermis or subcutaneous junction.
* **Cheeks/Chin/Temples:** Subcutaneous or supraperiosteal.
* **Post-Treatment:** Expect common side effects: Swelling, redness, tenderness, bruising (lidocaine’s mild vasoconstriction may slightly reduce risk). Avoid pressure/massage immediately post-injection.
* **Longevity:** Typically **6-9 months**, varying by area, metabolism, and technique.
* **Safety:** Standard dermal filler risks apply: Bruising, swelling, redness, nodules, infection, hypersensitivity (including to lidocaine). Vascular compromise risk necessitates proper anatomy knowledge and technique. Tyndall effect possible if injected too superficially. Nodule risk higher in lips if overcorrected.
* **Regulatory Status:** **CE marked** (Europe/international). **Not FDA-approved in the USA.**
* **Prescription:** Prescription medical device.

HyalDew MID with Lidocaine provides practitioners with a versatile, comfortable solution for achieving natural-looking, moderate volume correction and wrinkle reduction across the mid and lower face, combining balanced lifting power with essential integrated anesthesia.CONTACT US